Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features.
Natsumeda M, Chang M, Gabdulkhaev R, Takahashi H, Tsukamoto Y, Kanemaru Y, Okada M, Oishi M, Okamoto K, Rodriguez FJ, Kakita A, Fujii Y, Schreck KC. Natsumeda M, et al. Among authors: fujii y. Brain Tumor Pathol. 2021 Jul;38(3):228-233. doi: 10.1007/s10014-021-00407-0. Epub 2021 Jul 3. Brain Tumor Pathol. 2021. PMID: 34216310
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y. Kanemaru Y, et al. Among authors: fujii y. Acta Neuropathol Commun. 2019 Jul 25;7(1):119. doi: 10.1186/s40478-019-0774-7. Acta Neuropathol Commun. 2019. PMID: 31345255 Free PMC article.
Intraventricular pleomorphic xanthoastrocytoma with anaplastic features.
Fu YJ, Miyahara H, Uzuka T, Natsumeda M, Okamoto K, Hirose T, Fujii Y, Takahashi H. Fu YJ, et al. Among authors: fujii y. Neuropathology. 2010 Aug;30(4):443-8. doi: 10.1111/j.1440-1789.2009.01080.x. Epub 2009 Dec 28. Neuropathology. 2010. PMID: 20051018
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas.
Abe H, Natsumeda M, Kanemaru Y, Watanabe J, Tsukamoto Y, Okada M, Yoshimura J, Oishi M, Fujii Y. Abe H, et al. Among authors: fujii y. Neurol Med Chir (Tokyo). 2018 Jul 15;58(7):290-295. doi: 10.2176/nmc.ra.2018-0044. Epub 2018 May 31. Neurol Med Chir (Tokyo). 2018. PMID: 29848907 Free PMC article. Review.
EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma.
Nozawa T, Okada M, Natsumeda M, Eda T, Abe H, Tsukamoto Y, Okamoto K, Oishi M, Takahashi H, Fujii Y, Kakita A. Nozawa T, et al. Among authors: fujii y. Neurol Med Chir (Tokyo). 2019 Mar 15;59(3):89-97. doi: 10.2176/nmc.oa.2018-0078. Epub 2019 Feb 21. Neurol Med Chir (Tokyo). 2019. PMID: 30787232 Free PMC article.
Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children's Cancer Group.
Miyahara H, Natsumeda M, Kanemura Y, Yamasaki K, Riku Y, Akagi A, Oohashi W, Shofuda T, Yoshioka E, Sato Y, Taga T, Naruke Y, Ando R, Hasegawa D, Yoshida M, Sakaida T, Okada N, Watanabe H, Ozeki M, Arakawa Y, Yoshimura J, Fujii Y, Suenobu S, Ihara K, Hara J, Kakita A, Yoshida M, Iwasaki Y. Miyahara H, et al. Among authors: fujii y. Brain Tumor Pathol. 2021 Apr;38(2):109-121. doi: 10.1007/s10014-021-00396-0. Epub 2021 Mar 11. Brain Tumor Pathol. 2021. PMID: 33704596
4,436 results